Company Filing History:
Years Active: 2019
Title: Hui-Kang Liu: Innovator in Metabolic Disease Treatment
Introduction
Hui-Kang Liu is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of medicine, particularly in the treatment and prevention of metabolic diseases. His innovative work has the potential to impact many lives by addressing various health issues related to metabolism.
Latest Patents
Hui-Kang Liu holds a patent for the use of helminthostachys, ugonins, or flavone-based compounds for the treatment or prevention of metabolic diseases. This patent discloses the use of these compounds for addressing conditions such as metabolic syndrome, obesity, fatty liver, diabetes mellitus type 2, and cardiovascular diseases, among others. His research highlights the importance of these compounds in combating serious health issues.
Career Highlights
Hui-Kang Liu is affiliated with the National Research Institute of Chinese Medicine, which is part of the Ministry of Health and Welfare. His work at this esteemed institution has allowed him to focus on innovative research that bridges traditional medicine and modern scientific approaches.
Collaborations
Hui-Kang Liu has collaborated with notable colleagues, including Cheng F Huang and Keng-Chang Tsai. These partnerships have fostered a collaborative environment that enhances the research and development of effective treatments for metabolic diseases.
Conclusion
Hui-Kang Liu's contributions to the field of metabolic disease treatment through his innovative patent demonstrate his commitment to advancing medical science. His work not only showcases his expertise but also holds promise for improving health outcomes for individuals affected by metabolic disorders.